Patient-centered Self-administered Acupressure for Fatigue Management in Chinese Advanced Cancer Patients
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Advanced Cancer
Related studies linked through entity extraction aliases.
Descriptive Observational Study on the Characteristics of Advanced and Metastatic Melanoma in Spain
- Status
- RECRUITING
- Phase
- N/A
CVM-1118 and Sorafenib Combination in Subjects With Advanced Hepatocellular Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
AsiDNA (a DNA Repair Inhibitor) Administered IntraVenously in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Personalized Immunotherapy in Adults With Advanced Cancers Immunotherapy in Adults With Advanced Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Stress Management and Resilience Training (SMART) Intervention for Family Caregivers of Individuals With Advanced Cancer
- Status
- COMPLETED
- Phase
- NA
3D Prediction of Patient-Specific Response
- Status
- UNKNOWN
- Phase
- N/A
Immunotherapy of Advanced Cancer Using a Combination Nimotuzumab and NK Cells
- Status
- UNKNOWN
- Phase
- PHASE1
Pembrolizumab Plus Autologous Dendritic Cell Vaccine in Patients with PD-L1 Negative Advanced Mesothelioma Who Have Failed Prior Therapies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Oral AMXT 1501 Dicaprate in Combination With DFMO
- Status
- COMPLETED
- Phase
- PHASE1
Extra Layer Of Support
- Status
- COMPLETED
- Phase
- NA
Lenvatinib and Eribulin in Advanced Soft Tissue Sarcoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.
- Status
- TERMINATED
- Phase
- PHASE1
Uncertainty in Illness in Palliative Care: an Intervention for Family Caregivers
- Status
- UNKNOWN
- Phase
- NA
Pharmacokinetic and Safety Study of MRX-2843 in Adults With Relapsed/Refractory Advanced and/or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Phase II Study of RC48-ADC in Subjects With HER2 Positive Metastatic or Unresectable Urothelial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Molecular Tumor Board at the Center for Personalized Medicine Tübingen
- Status
- RECRUITING
- Phase
- N/A
A Study of CS1003 in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
An Investigational Study of Immunotherapy Combinations in Participants With Solid Cancers That Are Advanced or Have Spread
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
An Investigational Immunotherapy Study of BMS-986258 Alone and in Combination With Nivolumab in Participants With Solid Cancers That Are Advanced or Have Spread
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2